By Dr J Sia
Several studies have confirmed the advantages of the use of digital breast tomosynthesis (DBT) as an adjunct to digital mammography (DM) in population-based breast cancer screening studies. However the use of DBT in the surveillance of patients who have had breast cancer treatment has not been extensively investigated.
This article summarizes the findings of a first prospective study of the use of DBT in addition to 2D imaging in patients with a history of
breast cancer treatment. It was found that the use of adjunct DBT in addition to DM in such patients reduced the rate of indeterminate findings
and hence unnecessary investigations compared to DM alone.